Results 181 to 190 of about 4,816,806 (365)

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

open access: yesMolecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia   +17 more
wiley   +1 more source

MULTIPLE REGRESSION ANALYSIS OF MAIN ECONOMIC INDICATORS IN TOURISM

open access: yesRevista de Turism: Studii si Cercetari in Turism, 2009
This paper analysis the measure between GDP dependent variable in the sector of hotels and restaurants and the following independent variables: overnight stays in the establishments of touristic reception, arrivals in the establishments of touristic ...
Erika KULCSÁR
doaj  

Integration of single‐cell and bulk RNA‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer

open access: yesMolecular Oncology, EarlyView.
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley   +1 more source

Meta-analysis of variance in tDCS effects on response inhibition. [PDF]

open access: yesSci Rep
Lasogga L   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy